James Cavanaugh

James Cavanaugh

Director/Board Member at
SkinMedica, Inc.

Net worth: 190 928 $ as of 30/05/2026

89 year
Health Technology
Commercial Services
Finance

Profile

James H.
Cavanaugh
is currently Director at Diacrin, Inc. (Delaware) and SkinMedica, Inc., Managing Director & Partner at HealthCare Ventures LLC since 1989, and Trustee at the Gerald R.
Ford Presidential Foundation.
Former positions include Non-Executive Chairman at Shire Plc, Chairman at Diversa Corp., Vicuron Pharmaceuticals LLC, CardioKine, Inc., The Richard Nixon Foundation, and Shire Acquisition, Inc. (1999–2008).
Chairman at Verenium Corp.
(1992–2013).
Director roles at MedImmune LLC (2007), Middlebrook Pharmaceuticals, Inc. (1999–2010), PharmAthene, Inc. (2007–2011), Colorescience Corp., Unihealth America, Inc., Marine National Bank (Irvine, California) as Founding Director, Nixon Group, Senseonics, Inc., Xanodyne Pharmaceuticals, Inc., Orqis Medical Corp., Healthcare Acquisition Corp., National Venture Capital Association, Pharmaceutical Research & Manufacturers Association, Consumer Healthcare Products Association, and Cypherpunk Technologies, Inc. (Independent Director, 2016–2026).
Deputy Director at Domestic Policy Council.
President at Smithkline Beckman Corp, Smithkline & French Laboratories US, Inc. (1985–1989), Smithkline Clinical Laboratories (1981–1985), French Laboratories U.S., Inc. (1989), Allergan Sales LLC, and Allergan International.
Deputy Assistant Secretary at US Department of Health & Human Services.
Trustee at The National Center for Genome Resources.
Education includes undergraduate degree from Fairleigh Dickinson University (1959), graduate degree from the University of Iowa (1961), and doctorate from the University of Iowa (1964).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/04/2026 168,963 ( 0.16% ) 190 928 $ 30/05/2026

James Cavanaugh active positions

CompaniesPositionStart
Private Equity Investor 31/12/1988
Director/Board Member -
Director/Board Member -
Director/Board Member -

Former positions of James Cavanaugh

CompaniesPositionEnd
CYPHERPUNK TECHNOLOGIES INC. Director/Board Member 17/06/2026
VERENIUM CORP Chairman 30/10/2013
Director/Board Member 24/04/2011
Director/Board Member 19/03/2010
Chairman 22/05/2008
See the detail of James Cavanaugh's experience

Training of James Cavanaugh

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

38

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies38

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Retail Trade

Finance

Finance

Finance

Commercial Services

Health Technology

Consumer Services

Consumer Services

Electronic Technology

Health Technology

Health Services

Finance

Government

Government

Commercial Services

Commercial Services

Pharmaceutical Research & Manufacturers Association

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Smithkline & French Laboratories US, Inc.

Smithkline Clinical Laboratories

Distribution Services

French Laboratories U.S., Inc.

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. James Cavanaugh